Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with ...
Steris offers comprehensive sterilization and disinfection portfolios to healthcare providers, with 80% of their revenue being recurring. The company has a strong presence in the Applied Sterilization ...
STERIS plc’s STE Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. Service revenues ...
STERIS plc STE has been gaining from strong segmental growth. The integration of Cantel Medical continued successfully, strengthening STERIS’ Endoscopy offerings. However, a challenging macroeconomic ...
Narrow-moat Steris had a good fiscal third quarter, moderately exceeding both our expectations and consensus aggregated by FactSet. While operating costs were a bit higher than anticipated--due to ...
STERIS’ Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. Further, its services to ...